Table 1 Patients characteristics
Parameter | All patients (n = 50) |
|---|---|
Age, median (range) | 62 (36 to 77) |
Sex (male/female) | 34/16 |
ECOG performance status, n (0/1) | 49/1 |
Disease stage, n (%) | Â |
   M0/M1 | 15 (30)/35(70) |
   N0/N1,2 | 16 (32)/34 (68) |
   G1/2/3 | 7 (15)/41(81)/2 (4) |
Number of metastatic lesions (%) | Â |
   1 | 15 (30) |
   2–3 | 11 (22) |
   ≥ 4 | 24 (48) |
Lymph-node positive primary tumors, n (%) | 34 (68) |
Duration of metastatic disease < 12 months, n (%) | 37 (74) |
CEA > 20 ng/mL, n (%) | 15 (30) |
Synchronous metastases, n (%) | 35 (70) |